Psychopharmacology Reconsidered: A Concise Guide Exploring the Limits of Diagnosis and Treatment
暫譯: 精神藥理學再思考：探索診斷與治療界限的簡明指南

Belmaker, Robert Haim, Lichtenberg, Pesach

Psychopharmacology Reconsidered: A Concise Guide Exploring the Limits of Diagnosis and Treatment
  • 出版商: Springer
  • 出版日期: 2024-10-19
  • 售價: $2,560
  • 貴賓價: 9.5 折 $2,432
  • 語言: 英文
  • 頁數: 220
  • 裝訂: Quality Paper - also called trade paper
  • ISBN: 3031403738
  • ISBN-13: 9783031403736

    • 海外代購書籍(需單獨結帳)

相關主題

商品描述

This thought-provoking book covers the full range of psychopharmacologic practice in textbook fashion, offering a fresh and comprehensive self-examination. Unlike conventional texts of psychopharmacology, this text speaks directly to clinicians who have started to question the limitations of psychopharmacologic claims and the rigid confines of DSM-5 diagnoses. Drawing from their clinical and research experience as well as new literature, the well-published authors provide a new perspective that encourages readers to reevaluate established practices and embrace that medication is just one component of treatment and has limits. The book could be used by psychiatric residents in their course of study, by clinical psychology students taking a psychopharmacology course, or by psychiatrists curious to get a readable but comprehensive look at new critical viewpoints in psychopharmacology that have changed since they were taught. Many neuroscience students who are looking for areview of clinical effects to guide their basic research may also find the proposed text more useful than those texts that collate clinical trials.

Current texts are for specialized scientists or are part of multi-authored texts which list drugs alphabetically with no conceptual framework, or books that pretend that each biochemical drug property has a clear and known clinical result presented in cartoon style. Some lesser known texts for psychology or nursing students are not authoritative. Others aimed at patients or families are too simplistic for clinicians. The authors' goal was to create a unified text expressing their view of psychopharmacology, its evidence base, the unity of its essential principles, and its independence of DSM or ICD diagnosis.

Several new history books describe the "rise and fall" of psychopharmacology, the corruption of big pharma and the failure of large controlled clinical trials. Psychopharmacology Reconsidered: A Concise Guide Exploring the Limits of Diagnosis and Treatment ensures that young clinicians are aware of and understand this critical zeitgeist but aware also of the essential core of psychopharmacology and the evidence upon which it rests.

商品描述(中文翻譯)

這本引人深思的書以教科書的方式涵蓋了心理藥理學實踐的全範圍，提供了一個新穎且全面的自我檢視。與傳統的心理藥理學文本不同，本書直接針對那些開始質疑心理藥理學主張的局限性以及DSM-5診斷的僵化界限的臨床醫師。作者們根據他們的臨床和研究經驗以及新的文獻，提供了一種新的視角，鼓勵讀者重新評估既定的實踐，並接受藥物只是治療的一個組成部分，並且有其局限性。這本書可以供精神科住院醫師在學習過程中使用，臨床心理學學生在修習心理藥理學課程時參考，或是對於想要以可讀性強但全面的方式了解心理藥理學新批判觀點的精神科醫師。許多尋求臨床效果以指導基礎研究的神經科學學生也可能會發現這本書比那些彙整臨床試驗的文本更有用。

目前的文本要麼是針對專業科學家的，要麼是多位作者共同撰寫的文本，這些文本按字母順序列出藥物，卻沒有概念框架，或是那些假裝每種生化藥物特性都有明確且已知的臨床結果的書籍，這些結果以卡通風格呈現。一些針對心理學或護理學生的較不知名的文本並不具權威性。其他針對患者或家庭的書籍對臨床醫師來說過於簡化。作者的目標是創建一本統一的文本，表達他們對心理藥理學的看法、其證據基礎、其基本原則的統一性，以及其獨立於DSM或ICD診斷的特性。

幾本新的歷史書籍描述了心理藥理學的「興起與衰落」、大型製藥公司的腐敗以及大型控制臨床試驗的失敗。《心理藥理學再思：探索診斷與治療界限的簡明指南》確保年輕的臨床醫師意識到並理解這一關鍵的時代精神，同時也了解心理藥理學的基本核心及其所依賴的證據。

作者簡介

Robert Haim Belmaker, Division of Psychiatry, Ben-Gurion University of the Negev, Israel. belmaker@bgu.ac.il

Prof. Robert Haim Belmaker is an Israeli psychiatrist who has had major academic positions in Israeli psychiatry since 1974. He had a formative influence on biological directions in Israeli psychiatry. He was Professor of Psychiatry at Ben-Gurion University of the Negev, Beersheva Israel and is now Emeritus. He was President of the International College of Neuropsychopharmacology 2008-2010, Vice President of the International Society for Bipolar Disorders 2012-2014, President of the Israel Psychiatry Association 2015-2018 and is Fellow Emeritus of the American College of Neuropsychopharmacology. He has co-edited 18 books in psychopharmacology and authored over 400 original papers.

Pesach Lichtenberg, M.D., The Hebrew University in Jerusalem; Soteria Israel; and the Jerusalem Mental Health Center.

pesach.lichtenberg@mail.huji.ac.il

Prof. Pesach Lichtenberg has directed acute care psychiatric wards for 25 years, currently in the Jerusalem Mental Health Center. He served as the Academic Chair of Psychiatry at the Faculty of Medicine of the Hebrew University in Jerusalem. His academic work has covered psychopharmacology, diagnosis, hypnosis and placebo. His clinical and research activity in recent years focuses on the Soteria model for psychosis, which he brought to Israel, and which has catalyzed far-reaching changes in the public mental health care system.


作者簡介(中文翻譯)

羅伯特·海姆·貝爾梅克（Robert Haim Belmaker），以色列內蓋夫本·古里昂大學精神醫學系。 belmaker@bgu.ac.il

羅伯特·海姆·貝爾梅克教授是一位以色列精神科醫生，自1974年以來在以色列精神醫學界擔任重要的學術職位。他對以色列精神醫學的生物學方向產生了深遠的影響。他曾擔任以色列內蓋夫本·古里昂大學的精神醫學教授，現在是名譽教授。他於2008年至2010年擔任國際神經精神藥理學學院的會長，2012年至2014年擔任國際雙相障礙學會的副會長，2015年至2018年擔任以色列精神醫學協會的會長，並且是美國神經精神藥理學學院的名譽院士。他共同編輯了18本精神藥理學的書籍，並發表了超過400篇原創論文。

佩薩赫·利赫滕伯格（Pesach Lichtenberg），醫學博士，耶路撒冷希伯來大學；以色列索特里亞；耶路撒冷心理健康中心。

pesach.lichtenberg@mail.huji.ac.il

佩薩赫·利赫滕伯格教授在急性精神病護理病房工作了25年，目前在耶路撒冷心理健康中心任職。他曾擔任耶路撒冷希伯來大學醫學院的精神醫學學術主任。他的學術工作涵蓋精神藥理學、診斷、催眠和安慰劑。近年來，他的臨床和研究活動專注於他引入以色列的精神病索特里亞模型，該模型促成了公共心理健康護理系統的深遠變革。

類似商品